MedTrace Logo

Oral Margin Spectroscopy Detection Using Optical Spectroscopy

NCT00439205 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2017-10-20

No results posted yet for this study

Summary

The goal of this clinical research study is to evaluate an imaging technology that may help clinicians see how far an area of pre-cancerous or cancerous tissue extends in the mouth.

Conditions

  • Oral Tumors

Interventions

DEVICE

FastEEM4 System

The FastEEM4 probe is moved toward the edge of the lesion(s) until it measures what appears to be normal mouth tissue.

DEVICE

Multispectral Digital Microscope

The MDM instrument will take pictures of abnormal-appearing and normal-appearing areas in the mouth.

Sponsors & Collaborators

  • National Institute of Dental and Craniofacial Research (NIDCR)

    collaborator NIH

  • National Institutes of Health (NIH)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Ann M. Gillenwater, MD · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-07
Primary Completion
2017-10-10
Completion
2017-10-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00439205 on ClinicalTrials.gov